HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Announces 'Irresistible Superiority' Strategy To Win In Global Slump

This article was originally published in The Rose Sheet

Executive Summary

Firm's sales were down in all segments but health care in the third quarter, reflecting challenges it sees worldwide across consumer industries. In this environment, and facing the threat of commoditization in the categories where it competes, P&G is focused on delivering "irresistible superiority," a strategy that drew questions from analysts as to how exactly it will translate to wins in practice.

You may also be interested in...



P&G Looks To Follow Brand Trimming By Spreading Through M&A

P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. However, analysts ask whether P&G, under pressure from an activist investor, has entered a growth era or is pushing a “false positive.”

If P&G Seeks OTC Sale, Pharma Buyers Might Line Up

P&G's activist investor Trian Fund Management is known for pressuring big companies to break up. The OTC business would likely have plenty of potential buyers.

P&G Could Lean Toward OTC Brand Sales With Activist Investor Influence

Analysts consider the potential for P&G splitting up or selling OTC or beauty care assets following CEO David Taylor's recent comments on possible moves with activist investor Trian. Analysts weigh in on the potential for sale or swap of brands and whether the moves would help.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel